FDA EIR - Catalent Maryland Inc - November 17, 2021
FDA EIR for Catalent Maryland Inc on November 17, 2021. Product: Biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA EIR for Catalent Maryland Inc on November 17, 2021. Product: Biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Catalent Maryland IncInspection Date
November 17, 2021
Product Type
Biologics
ID: 03bb4edc-783b-4f67-85cd-78c9ab7171f4
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox